<!doctype html><html><head><meta charset=utf-8><title>Multiple Sclerosis treatment not helped by small doses of vitamin D (yet again) – meta-analysis</title>
<link rel=stylesheet href="/css/main.css?v=1748382337"><link rel=stylesheet href="/css/pagination.css?v=1748382337"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748382337"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Multiple Sclerosis treatment not helped by small doses of vitamin D (yet again) – meta-analysis</h1><time>January 12, 2024</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#vitamin-d3-as-an-add-on-treatment-for-multiple-sclerosis-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials>Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials</a></li></ul></li></ul></li></ul></nav><hr><h4 id=vitamin-d3-as-an-add-on-treatment-for-multiple-sclerosis-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials>Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials</h4><p>Mult Scler Relat Disord . 2024 Jan 6:82:105433. <a href=https://doi.org/10.1016/j.msard.2024.105433>doi: 10.1016/j.msard.2024.105433</a> PDF I behind a paywall</p><p>João Vitor Mahler 1, Marina Solti 2, Samira Luísa Apóstolos-Pereira 3, Tarso Adoni 3, Guilherme Diogo Silva 3, Dagoberto Callegaro 3</p><p>Background: Vitamin D deficiency has been linked to a higher risk of multiple sclerosis (MS) and disease progression. However, the efficacy of vitamin D3 as an adjuvant therapy for MS remains a controversial topic.</p><p>Objective: To perform a systematic review and meta-analysis of randomized controlled trials to assess the impact of adjunct high-dose vitamin D3 on clinical and radiological outcomes.</p><p>Methods: PubMed, Embase, and Cochrane Library were searched for trials published until December 18th, 2022. Authors independently selected randomized controlled trials involving patients with MS, with an intervention group receiving high dose <strong>(≥ 1000 IU/day)</strong> cholecalciferol and reporting clinical or radiological outcomes. Authors independently extracted data and assessed the risk of bias using a standardized, pilot-tested form. The meta-analysis was conducted using RStudio for EDSS at the last follow-up, ARR, and new T2 lesion count.</p><p>Results: We included 9 studies with 867 participants. No significant reduction of EDSS (MD = 0.02, CI 95 % <span>[-0.37; 0.41]</span>, p = 0.91), ARR (MD -0.03, CI 95 % <span>[-0.08; 0.02]</span>, p = 0.26), or new T2 lesions (MD -0.59, CI 95 % <span>[-1.24;0.07]</span>, p = 0.08) was observed at 6-24 months. We found no evidence of publication bias.</p><p>Conclusion: The findings of this meta-analysis strengthen current evidence that vitamin D3 supplementation has no significant impact on clinical outcomes in patients with MS. However, the non-significant reduction of new T2 lesions could precede long-term clinical benefits and should be validated in additional studies.</p></article></div></div><script src="/js/lightspa.js?v=1748382337"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748382337",indexUrl:"/search/search_index.json.gz?v=1748382337"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748382337"></script><script src="/js/search-results-panel.js?v=1748382337"></script><script src="/js/tiki-redirects.js?v=1748382337"></script></body></html>